Holen Sie sich die Stockscreener-App
11.45
6.22%
-0.76
Handel nachbörslich:
12.02
0.57
+4.98%
Neumora Therapeutics Inc Aktie (NMRA) Neueste Nachrichten
Critical Analysis: Neumora Therapeutics (NMRA) and The Competition - Defense World
Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - The Manila Times
(NMRA) On The My Stocks Page - Stock Traders Daily
Neumora Therapeutics (NASDAQ:NMRA) Trading Down 4.5%Time to Sell? - MarketBeat
Neumora Therapeutics (NASDAQ:NMRA) Sees Large Volume IncreaseTime to Buy? - MarketBeat
Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Down Following Insider Selling - Defense World
SG Americas Securities LLC Lowers Holdings in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World
Bleakley Financial Group LLC Sells 1,966 Shares of Vanguard Mid-Cap Growth ETF (NYSEARCA:VOT) - Defense World
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Shares Sold by SG Americas Securities LLC - MarketBeat
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Director Sells $239,254.47 in Stock - MarketBeat
Neumora Therapeutics director Matthew Fust sells $370,961 in stock - Investing.com India
Neumora Therapeutics director Matthew Fust sells $370,961 in stock By Investing.com - Investing.com South Africa
Neumora Therapeutics (NASDAQ:NMRA) Rating Reiterated by Needham & Company LLC - MarketBeat
(NMRA) Investment Analysis - Stock Traders Daily
This trade activity should not be overlooked: Neumora Therapeutics Inc. (NMRA) - SETE News
Neumora Therapeutics: A Story Of A Class II Biotech (NASDAQ:NMRA) - Seeking Alpha
Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Down After Insider Selling - Defense World
Have you been able to find a good deal on Neumora Therapeutics Inc.’s shares? - US Post News
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Shares Acquired by The Manufacturers Life Insurance Company - MarketBeat
Acrivon Therapeutics Launches Phase 1 Cancer Trial, Advances Oncology Pipeline - Yahoo Finance
Neumora Therapeutics executive sells over $200k in company stock By Investing.com - Investing.com Australia
Neumora Therapeutics executive sells over $200k in company stock - Investing.com India
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Insider Robert A. Lenz Sells 5,563 Shares - MarketBeat
Neumora Therapeutics Inc. [NMRA] Records 50-Day SMA of $12.22 - Knox Daily
Neumora Therapeutics Inc.: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - The InvestChronicle
Neumora Therapeutics (NASDAQ:NMRA) Shares Up 6.6%Here's What Happened - MarketBeat
Market Momentum Report: Neumora Therapeutics Inc. (NMRA)’s Positive Close at 14.74 - The Dwinnex
Does Neumora Therapeutics Inc. (NMRA) offer a good opportunity for investors? - SETE News
What is the investor’s view on Neumora Therapeutics Inc. (NMRA)? - US Post News
Marshall Wace LLP Purchases New Stake in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - MarketBeat
Neumora Therapeutics (NASDAQ:NMRA) Trading 7.5% HigherStill a Buy? - MarketBeat
Will Neumora's Alzheimer's Agitation Therapy Be Able To Excite Investors? - RTTNews
Neumora Therapeutics, Inc. (NASDAQ:NMRA) to Post Q3 2024 Earnings of ($0.33) Per Share, HC Wainwright Forecasts - MarketBeat
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Shares Purchased by Amalgamated Bank - Defense World
Potential Price Increase for Neumora Therapeutics Inc. (NMRA) After Recent Insider Activity - Knox Daily
Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Down to $13.50 - MarketBeat
Logos Global Management LP Reduces Position in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World
Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Up to $13.21 - MarketBeat
Neumora Therapeutics (NASDAQ:NMRA) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Neumora Therapeutics (NASDAQ:NMRA) Coverage Initiated at HC Wainwright - Defense World
What was Neumora Therapeutics Inc. (NMRA)’s performance in the last session? - US Post News
Neumora Therapeutics' SWOT analysis: navacaprant's potential lifts stock outlook - Investing.com
Stock Performance Spotlight: Neumora Therapeutics Inc. (NMRA) Ends the Day at 12.92, Down by -1.22 - The Dwinnex
A History of Outperforming Analyst Forecasts and Beating the Odds: Neumora Therapeutics Inc. (NMRA) - SETE News
Neumora Therapeutics' SWOT analysis: navacaprant's potential lifts stock outlook By Investing.com - Investing.com UK
1.11%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):